Showing results (661-670 of 712) with videos related to

Sort By:
Pageof 72
AIDS (London, England)|December 31, 2008
Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients: 48-week results of a phase IIb trialCalvin J Cohen, Daniel S Berger, Gary Blick, et al.
Journal of Neurosurgery|December 3, 2008
Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiformeMatthew J McGirt, Khoi D Than, Jon D Weingart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 1, 1996
Delayed function reduces renal allograft survival independent of acute rejectionH I Feldman, R Gayner, J A Berlin, et al.
Journal of Neuro-Oncology|August 20, 2015
Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomasJaishri O Blakeley, Stuart A Grossman, Tom Mikkelsen, et al.
Transplantation|August 2, 2002
Comparison of open, laparoscopic, and hand-assisted approaches to live-donor nephrectomyErgun Velidedeoglu, Noel Williams, Kenneth L Brayman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Phase I and correlative biology study of cilengitide in patients with recurrent malignant gliomaL Burt Nabors, Tom Mikkelsen, Steven S Rosenfeld, et al.
Fluids and Barriers of the CNS|January 16, 2018
The effect of an adenosine A<sub>2A</sub> agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastomaSadhana Jackson, Jon Weingart, Edjah K Nduom, et al.
Transplantation|December 14, 2004
Expanded-criteria donor kidneys: a single-center clinical and short-term financial analysis--cause for concern in retransplantationMarty T Sellers, Ergun Velidedeoglu, Roy D Bloom, et al.
Pageof 72